Literature DB >> 12861514

[Orally administered drugs in the treatment of spasticity].

J Campistol1.   

Abstract

Spasticity is a common problem in paediatric neurology and its management constitutes a real professional challenge. There are numerous therapeutic options available and their advantages and disadvantages should be carefully weighed up for each individual patient. It is true that we do not have one single final option, but experience and knowledge of the therapeutic possibilities favour the functional improvement of patients suffering from spasticity. In this paper, we analyse the different drugs available for oral administration in the treatment of spasticity. Special attention is given to the side effects and interactions of these drugs in multiple deficiency patients, who are usually already receiving other medication. We review the mechanism of action, the forms of presentation and dosage, the side effects and interactions of baclofen, diazepam, clonidine, tizanidine, modafilin, gabapentin and dantrolene. Finally, other drugs that may be useful in improving spasticity are also analysed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861514

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  3 in total

1.  Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.

Authors:  Herbert R Henney; Michael Chez
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

2.  Surgical management of intractable spasticity.

Authors:  Mohamed I Barakat; Waleed Elhady; Mohamed Gouda; Mahmoud Taha; Ibrahim Metwaly
Journal:  Eur Spine J       Date:  2015-12-14       Impact factor: 3.134

Review 3.  Spasticity - Pathogenesis, prevention and treatment strategies.

Authors:  Anju Ghai; Nidhi Garg; Sarla Hooda; Tushar Gupta
Journal:  Saudi J Anaesth       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.